EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis

Qin Qin, Mao Wang, Yu Zou, Dujiang Yang, Yuchuan Deng, Shuyu Lin, Yiran Song, Rui Li, Yu Zheng

MedComm – Biomaterials and Applications · 2023-12 · 2 (4)

DOI: 10.1002/mba2.65 ↗

At a glance

Journal article in MedComm – Biomaterials and Applications, published online on 2023-12-06. Written by Qin Qin and 8 co-authors. Cited 18 times so far (Crossref); 145 references. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Inflammation is a prevalent pathological process that accompanies the onset and progression of numerous acute and chronic diseases including rheumatoid arthritis, sepsis, pancreatitis, atherosclerosis, ischaemic brain/heart disease and so forth. However, conventional anti‐inflammatory drugs have certain disadvantages such as nonspecific tissue distribution, low bioavailability, and a short half‐life, resulting in off‐target side effects and limited efficacy in disease control. To address these issues, nanoparticles have emerged as a novel therapeutic paradigm in this field to attain inflammation targeting and improve drug pharmacokinetic properties via the well‐recognized enhanced permeability and retention (EPR) effect at the inflammatory site. Existing reviews are predominantly centered on inflammatory pathology introduction and vector design. As a necessary complement, this review mainly elaborates on the introduction of inflammation core events, the history of the drug delivery system for anti‐inflammatory drugs, the action mechanism of inflammation targeting vectors, nanoparticle classification based on targeting moiety, methods to combine targeting moiety with core nanoparticles, techniques to assess targetability in vitro and in vivo and finally the challenges and prospects in this field. The information provided herein offers practical guidance to researchers seeking to develop and evaluate inflammation targeting vectors rationally.

Cite

APA

Qin, Q., Wang, M., Zou, Y., Yang, D., Deng, Y., Lin, S., Song, Y., Li, R., & Zheng, Y. (2023). Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis. MedComm – Biomaterials and Applications, 2(4). https://doi.org/10.1002/mba2.65

Vancouver

Qin Q, Wang M, Zou Y, Yang D, Deng Y, Lin S, et al. Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis. MedComm – Biomaterials and Applications. 2023;2(4). doi:10.1002/mba2.65

BibTeX
@article{Qin2023,
  author = {Qin, Qin and Wang, Mao and Zou, Yu and Yang, Dujiang and Deng, Yuchuan and Lin, Shuyu and Song, Yiran and Li, Rui and Zheng, Yu},
  title = {Development of nanoparticle‐based drug delivery system for inflammation treatment and diagnosis},
  journal = {MedComm – Biomaterials and Applications},
  year = {2023},
  volume = {2},
  number = {4},
  doi = {10.1002/mba2.65}
}
Start for free →